366
Views
61
CrossRef citations to date
0
Altmetric
Review

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review

, , , , , & show all
Pages 719-735 | Published online: 31 Mar 2016

References

  • PattenSBBeckCMajor depression and mental health care utilization in Canada: 1994 to 2000Can J Psychiatry200449530330915198466
  • KukrejaSKalraGShahNShrivastavaAPolypharmacy in psychiatry: a reviewMens Sana Monogr2013111829923678240
  • GoldbergJFBrooksJO3rdKuritaKDepressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BDJ Clin Psychiatry200970215516219210946
  • ZarateCAJrQuirozJACombination treatment in bipolar disorder: a review of controlled trialsBipolar Disord20035321722512780875
  • PreskornSHLaceyRLPolypharmacy: when is it rational?J Psychiatr Pract20071329710517414685
  • McInerneySJKennedySHReview of evidence for use of antidepressants in bipolar depressionPrim Care Companion CNS Disord2014165
  • FornaroMMartinoMDe PasqualeCMoussaouiDThe argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states?Expert Opin Pharmacother201213142037205122946746
  • El-MallakhRSGaoYJeannie RobertsRTardive dysphoria: the role of long term antidepressant use in-inducing chronic depressionMed Hypotheses201176676977321459521
  • ZigmanDBlierPA framework to avoid irrational polypharmacy in psychiatryJ Psychopharmacol201226121507151122767374
  • SachsGSThaseMEOttoMWRationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)Biol Psychiatry200353111028104212788248
  • PerlisRHOstacherMJPatelJKPredictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD)Am J Psychiatry2006163221722416449474
  • LinDMokHYathamLNPolytherapy in bipolar disorderCNS Drugs2006201294216396522
  • PerugiGFornaroMBipolar disorder treatment guidelines and their limits in every day clinical practiceGiorn Ital Psicopat2011173261264
  • VietaETreatment guidelines for bipolar disorder: a bit unrealistic, but indispensableGiorn Ital Psicopat201016380388
  • GhaemiSNPolypharmacy in PsychiatryAbingdonTaylor & Francis2002
  • NiculescuAB3rdPolypharmacy in oligopopulations: what psychiatric genetics can teach biological psychiatryPsychiatr Genet200616624124417106426
  • HealyDPsychiatric Drugs Explained5th edLondonElsevier2009
  • ParisJThe Use and Misuse of Psychiatric Drugs: An Evidence-Based CritiqueHoboken, NJJohn Wiley & Sons2010
  • GallegoJABonettiJZhangJKaneJMCorrellCUPrevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009Schizophr Res20121381182822534420
  • MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
  • QiXYangMRenWFind duplicates among the PubMed, EMBASE, and Cochrane Library Databases in systematic reviewPLoS One201388e7183823977157
  • McGauranNWieselerBKreisJSchülerYBKölschHKaiserTReporting bias in medical research – a narrative reviewTrials2010113720388211
  • SachsGSPetersATSylviaLGrunzeHPolypharmacy and bipolar disorder: what’s personality got to do with it?Int J Neuropsychopharmacol20141771053106124067291
  • HowlandRHPharmacotherapy of inpatients with bipolar depressionAnn Clin Psychiatry1997941992029511942
  • HaeberleAGreilWRussmannSGrohmannRMono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPBMC Psychiatry20121215322998655
  • KupferDJFrankEGrochocinskiVJClussPAHouckPRStapfDADemographic and clinical characteristics of individuals in a bipolar disorder case registryJ Clin Psychiatry200263212012511874212
  • WeinstockLMGaudianoBAEpstein-LubowGTezanosKCelis-DehoyosCEMillerIWMedication burden in bipolar disorder: a chart review of patients at psychiatric hospital admissionPsychiatry Res20142161243024534121
  • HungGCYangSYChenYLinSKPsychotropic polypharmacy for the treatment of bipolar disorder in TaiwanPsychiatr Serv201465112512824382766
  • BaekJHHaKYathamLNPattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelinesJ Clin Psychopharmacol201434557758725006813
  • MauerSAlahmariRVohringerPAInternational prescribing patterns for mood illness: the International Mood Network (IMN)J Affect Disord201416713613924955565
  • OkashaTAKucukalicANasrAALonger-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and AfricaCurr Med Res Opin20092581889190019538106
  • PeindlKSMasandPMannelliPNarasimhanMPatkarAPolypharmacy in pregnant women with major psychiatric illness: a pilot studyJ Psychiatr Pract200713638539218032983
  • GreilWHaberleAHaueisPGrohmannRRussmannSPharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009J Affect Disord2012136353454222134044
  • BauerMGlennTAldaMDrug treatment patterns in bipolar disorder: analysis of long-term self-reported dataInt J Bipolar Disord20131525505672
  • BauerMGlennTGrofPThe association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorderHum Psychopharmacol2010251475420033908
  • HuffmanJCChangTEDurhamLEWeissAPAntipsychotic polytherapy on an inpatient psychiatric unit: how does clinical practice coincide with Joint Commission guidelines?Gen Hosp Psychiatry201133550150821762994
  • GazalleFKHallalPCTramontinaJPolypharmacy and suicide attempts in bipolar disorderRev Bras Psiquiatr2007291353817435926
  • CorrellCUFredericksonAMKaneJMManuPDoes antipsychotic polypharmacy increase the risk for metabolic syndrome?Schizophr Res2007891–39110017070017
  • BaldessariniRJPerryRPikeJFactors associated with treatment nonadherence among US bipolar disorder patientsHum Psychopharmacol20082329510518058849
  • LevineJChengappaKNBrarJSGershonSKupferDJIllness characteristics and their association with prescription patterns for bipolar I disorderBipolar Disord200131414911256463
  • LevineJChengappaKNBrarJSPsychotropic drug prescription patterns among patients with bipolar I disorderBipolar Disord20002212013011252651
  • AdliMWhybrowPCGrofPUse of polypharmacy and self-reported mood in outpatients with bipolar disorderInt J Psychiatry Clin Pract20059425125624930922
  • KamathJTemporiniHQuartiSBest practices: disseminating best practices for bipolar disorder treatment in a correctional populationPsychiatr Serv201061986586720810582
  • MorratoEHDoddSOderdaGHaxbyDGAllenRValuckRJPrevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998–2003Clin Ther200729118319517379060
  • CentorrinoFCincottaSLTalamoAHospital use of antipsychotic drugs: polytherapyCompr Psychiatry2008491656918063043
  • CentorrinoFGorenJLHennenJSalvatorePKelleherJPBaldessariniRJMultiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefitsAm J Psychiatry2004161470070615056517
  • AparasuRRJanoEBhataraVConcomitant antipsychotic prescribing in US outpatient settingsRes Soc Adm Pharm200953234241
  • JordanovaVMaricNPAlikajVPrescribing practices in psychiatric hospitals in Eastern EuropeEur Psychiatry201126741441820828993
  • DolsARhebergenDBeekmanAKupkaRSajatovicMStekMLPsychiatric and medical comorbidities: results from a bipolar elderly cohort studyAm J Geriatr Psychiatry201422111066107424495405
  • HurleyADFolsteinMLamNPatients with and without intellectual disability seeking outpatient psychiatric services: diagnoses and prescribing patternJ Intellect Disabil Res200347pt 1395012558694
  • BauerRGlennTAldaMAntidepressant dosage taken by patients with bipolar disorder: factors associated with irregularityInt J Bipolar Disord201312625505689
  • BushardtRLMasseyEBSimpsonTWAriailJCSimpsonKNPolypharmacy: misleading, but manageableClin Interv Aging20083238338918686760
  • GilletteCPruntyLWolcottJBroedel-ZauggKA new lexicon for polypharmacy: implications for research, practice, and educationRes Social Adm Pharm201511346847125280463
  • JorgensenTJohanssonSKennerfalkAWallanderMASvärdsuddKPrescription drug use, diagnoses, and healthcare utilization among the elderlyAnn Pharmacother20013591004100911573845
  • LinjakumpuTHartikainenSKlaukkaTVeijolaJKiveläSLIsoahoRUse of medications and polypharmacy are increasing among the elderlyJ Clin Epidemiol200255880981712384196
  • Lopez-Torres HidalgoJCerda DiazRFernandez OlanoCRequena GallegoMFernández CasalderreyCOtero PuimeAFactors associated with chronic drug consumption in the elderlyMed Clin199710815572576
  • KingsburySJYiDSimpsonGMPsychopharmacology: rational and irrational polypharmacyPsychiatr Serv20015281033103611474046
  • KrishnanKRPsychiatric and medical comorbidities of bipolar disorderPsychosom Med20056711815673617
  • KupferDJThe increasing medical burden in bipolar disorderJAMA2005293202528253015914754
  • EngelRRGrohmannRRutherEHippiusHResearch methods in drug surveillancePharmacopsychiatry200437suppl 1S12S1515052510
  • GrohmannREngelRRRutherEHippiusHThe AMSP drug safety program: methods and global resultsPharmacopsychiatry200437suppl 1S4S1115052509
  • AzorinJMAubrunEBertschJReedCGerardSLukasiewiczMMixed states vs pure mania in the French sample of the EMBLEM study: results at baseline and 24 months – European mania in bipolar longitudinal evaluation of medicationBMC Psychiatry200993319500417
  • BaldessariniRHenkHSklarAChangJLeahyLPsychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherencePsychiatr Serv200859101175118318832504
  • HayesJPrahPNazarethIPrescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009PLoS One2011612e2872522163329
  • QuanteAZeugmannSRegenFEngelhardtAAnghelescuIGPsychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in GermanyPsychiatry Investig201073155162
  • WHOWHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index 2011GenevaWorld Health Organization2013
  • BarnettJHHuangJPerlisRHPersonality and bipolar disorder: dissecting state and trait associations between mood and personalityPsychol Med20114181593160421134316
  • CorrellCUDetrauxJDe LepeleireJDe HertMEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorderWorld Psychiatry201514211913626043321
  • VincentiAVentriglioABaldessariniRJTalamoAFitzmauriceGCentorrinoFCharacteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disordersPharmacopsychiatry201043622523220652858
  • KamathJWakaiSZhangWKestenKSheltonDTrestmanRAdaptation of the Texas implementation medication algorithm for bipolar disorder in adult female offendersInt J Offender Ther Comp Criminol Epub2015331
  • DautzenbergGLansLMeestersPDThe care needs of older patients with bipolar disorderAging Ment Health Epub2015651926046823
  • DiasVVBalanza-MartinezVSoeiro-de-SouzaMGPharmacological approaches in bipolar disorders and the impact on cognition: a critical overviewActa Psychiatr Scand2012126531533122881296
  • GuilletteLMHollisKLMarkarianALearning in a sedentary insect predator: antlions (Neuroptera: Myrmeleontidae) anticipate a long waitBehav Processes200980322423220522313
  • FornaroMCiampaGMostiNDel CarloACeraudoGColicchioSA case of treatment resistant depression and alcohol abuse in a person with mental retardation: response to aripiprazole and fluvoxamine therapy upon consideration of a bipolar diathesis after repetitive failure to respond to multiple antidepressant trialsCase Report Med20102010801514
  • DesaiSDPandyaRHStudy of psychiatric comorbidity in patients with headache using a short structured clinical interview in a rural neurology clinic in Western IndiaJ Neurosci Rural Pract20145suppl 1S39S4225540537
  • PincusSMGladstoneIMEhrenkranzRAA regularity statistic for medical data analysisJ Clin Monit1991743353451744678
  • YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord200911322525519419382
  • APAAmerican Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006Arlington, VAAPA2006
  • GrunzeHVietaEGoodwinGMThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute maniaWorld J Biol Psychiatry20091028511619347775
  • FornaroMClementiNFornaroPMedicine and psychiatry in Western culture: Ancient Greek myths and modern prejudicesAnn Gen Psychiatry200982119811642
  • BrometEJKotovRFochtmannLJDiagnostic shifts during the decade following first admission for psychosisAm J Psychiatry2011168111186119421676994
  • DeshmukhSAIsmailTSEvaluation of psychotropic drugs use pattern among out patients attending psychiatry department at Government Medical College and Hospital, Nagpur: a cross sectional studyInt J Pharm Bio Sci201233428436
  • OdejideAOA study of the inpatient service of a Nigerian Psychiatric HospitalCompr Psychiatry19802143023077398254
  • AdeponleABObembeAOAdeyemiSOSuleimanGTPolypharmacy in psychiatric out-patient practice in northern NigeriaAfr J Psychiatry2007104215218
  • LakeCRSchizophrenia Is a Misdiagnosis: Implications for the DSM-5 and the ICD-11BerlinSpringer Science & Business Media2012
  • ChenYRSwannACBurtDBStability of diagnosis in schizophreniaAm J Psychiatry199615356826868615415
  • RenéSPhilippe Pinel et son Oeuvre Au Point de Vue de la Médecine MentaleLondonForgotten Books2013130131 Original work published 1890
  • FryeMAKetterTALeverichGSThe increasing use of polypharmacotherapy for refractory mood disorders: 22 years of studyJ Clin Psychiatry200061191510695639
  • FornaroMAgugliaEDell’OssoLPerugiGCould the underestimation of bipolarity obstruct the search for novel antidepressant drugs?Expert Opin Pharmacother201112182817283122098226
  • BlierPThe well of novel antidepressants: running dryJ Psychiatry Neurosci201035421922020569647